OTC Drugs To Propel The Global Allergy Diagnostics And Treatment Market Growth At 5.27% CAGR By 2027

Triton Market Research presents their Global allergy diagnostics and treatment market report segmented by immunotherapy (Sublingual Liquid Solutions, Subcutaneous Administration and Sublingual Tablets), by diagnostics (antibody and skin testing), by treatments (availability, administration and products) and by geographical region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) - discussing Industry Value Chain Analysis, Porter's 5 Force Analysis, Drivers, Restraints, Vendor Profiles, Global Market Size, Forecasts & Analysis (2019-2027).

Allergies generally occur due to an immune response of the body to fur, any particular food or dust or pollen. In case of an allergic reaction, the body becomes hypersensitive leading to discomfort. Patients suffering from any allergic diseases experience a low quality of life, and thus globally there is an increased demand for allergy diagnostics and treatment options. Triton Market Research expects the global allergy diagnostics and treatment market to witness a compound annual growth rate of 5.27% during the forecasted period of 2019-2027.

The most profiting market segment for the year 2018 has been the over the counter drug segment. Some of their popular types include antihistamines, nasal steroids, and allergy shots.  Presently, the market has been facing challenges in terms of expiry of major drugs in the offing, easy accessibility of generic drugs in the market, and the availability of alternative treatments. However, prospects like growing awareness about allergic diseases and high growth opportunities in developing economies are expected to propel the market ahead over 2019-2027.

The key geographies covered for this market are Europe, Asia-Pacific, North America, Latin America and the Middle East and Africa. North America presently accounts for a significant share in this market. Allergies are the 6th leading cause of chronic illness in the U.S. Thus, the region provides immense opportunities for the expansion of the immunotherapy segment. The fact that this region is home to some of the biggest pharmaceutical companies also contributes to the market’s progress.

Triton Market Research report discusses the analysis for each of the companies in allergy diagnostic and treatment market in detail. Some of the prominent companies that are profiled in this report include GlaxoSmithKline PLC, Pfizer, Johnson & Johnson, Sanofi, F. Hoffmann-La Roche Ltd., Allergan PLC, Beckmann Coulter, Hitachi Chemical Diagnostics Inc., Sanofi, Merck and Beckmann Coulter.